Compare CSX Corporation (CSX) vs Moderna, Inc. (MRNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CSX Corporation vs Moderna, Inc. — how do they compare? CSX Corporation trades at $50.03 (market cap $92.55B), while Moderna, Inc. trades at $60.83 (market cap $24.18B). The key difference: CSX Corporation is far larger — about 3.8× Moderna, Inc.'s market cap, and CSX Corporation pays a 1.12% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| CSX | MRNA | |
|---|---|---|
Market Cap | $92.55B | $24.18B |
Sector | Industrials | Health |
52-Week High | $53.21 | $81.80 |
52-Week Low | $32.05 | $22.36 |
Enterprise Value | $110.52B | $20.33B |
Dividend Yield | 1.12% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About CSX Corporation
Operating in the Eastern United States, Class I railroad CSX generated revenue near $12.5 billion in 2021. On its more than 21,000 miles of track, CSX hauls shipments of coal (13% of consolidated revenue), chemicals (22%), intermodal containers (16%), automotive cargo (9%), and a diverse mix of other bulk and industrial merchandise.
Read more on CSX →About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →
